TP53 and pancreatic neoplasm: Pancreatic cancer is characterized by multiple genomicalterations, including KRAS mutations, TP53 mutations and CDKN2A deletion.However, the prognostic relevance of those genomic alterations and associatedtranscriptomic profiling in pancreatic cancer are unclear.